Biogen Pharmachem Industries Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Biogen Pharmachem Industries Ltd. on BSE

Search Inside the pdf :

Biogen Pharmachem Industries Ltd.

25 Aug 2025

0.90

1.12%

Corp. Note

Biogen Pharmachem Industries Ltd - 531752 - Reg. 34 (1) Annual Report.

BSE India

Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual Report of the Company for the financial year 2024-25 along with the Notice of Annual General Meeting to be held on 25.09.2025

pdf

Biogen Pharmachem Industries Ltd.

25 Aug 2025

0.90

1.12%

Corp. Action

Biogen Pharmachem Industries Ltd - 531752 - Intimation Of Book Closure Pursuant To Regulation 42 Of …

BSE India

PFA

pdf

Biogen Pharmachem Industries Ltd.

25 Aug 2025

0.90

1.12%

AGM

Biogen Pharmachem Industries Ltd - 531752 - Submission Of Notice Of Annual General Meeting Under Regulation …

BSE India

PFA

pdf

Biogen Pharmachem Industries Ltd.

23 Jul 2025

0.90

1.12%

Company Update

Biogen Pharmachem Industries Ltd - 531752 - Nil Statement On Deviation Or Variation Of Funds Raised …

BSE India

PFA

pdf

Biogen Pharmachem Industries Ltd.

23 Jul 2025

0.90

1.12%

Result

Biogen Pharmachem Industries Ltd - 531752 - Regulations 30, 33 And Other Applicable Provisions Of The …

BSE India

PFA

pdf

	Jun 2025	Mar 2025	Jun 2024	Change QoQ%	Change YoY%
Total Revenue Qtr	1.54	1.35	-0.09	14.1%	1811.1%
Operating Profit Qtr	1.34	-0.17	-0.16	888.2%	937.5%
Net Profit Qtr	1.34	1.18	-0.16	13.6%	937.5%
Earning Per Share Adjusted latest Qtr	0.01	0.01	-0.00	0.0%	-

* Standalone data

Detailed Results

Biogen Pharmachem Industries Ltd.

23 Jul 2025

0.90

1.12%

Board Meeting

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Outcome for Outcome Of The Board Meeting …

BSE India

Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Wednesday 23rd July 2025 at the Registered Office of the Company and transacted the following major businesses: 1.) Considered and approved Un-audited financial results for the quarter ended as on 30th June, 2025. The board meeting commented at 04:15 PM and concluded at 04:40 PM Please take the above intimation in your records. Thanking You.

pdf

Biogen Pharmachem Industries Ltd.

16 Jul 2025

0.90

1.12%

Board Meeting

Biogen Pharmachem Industries Ltd - 531752 - Board Meeting Intimation for Compliance Of Regulation 29 Of …

BSE India

Biogen Pharmachem Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company will be held on Wednesday 23rd July 2025 inter alia, to consider following business. - 1.) To approve and take on record the Un-Audited Financial Results of the Company for first quarter ended on 30th June 2025. 2.) Any other matter with the permission of the board which the Board may think fit. Please take the above intimation in your records. Thanking You.

pdf